These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 35260168)
1. Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma. Yin T; Zhao L; Yao S BMC Med Genomics; 2022 Mar; 15(1):53. PubMed ID: 35260168 [TBL] [Abstract][Full Text] [Related]
2. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Huang X; Qiu Z; Li L; Chen B; Huang P Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607 [TBL] [Abstract][Full Text] [Related]
3. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer. Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046 [TBL] [Abstract][Full Text] [Related]
4. The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy. Zou R; Liu Y; Qiu S; Lu Y; Chen Y; Yu H; Zhu H; Zhu W; Zhu L; Feng J; Han J Cancer Biomark; 2023; 38(4):551-566. PubMed ID: 38007640 [TBL] [Abstract][Full Text] [Related]
5. m6A regulator-mediated methylation modification highlights immune infiltration patterns for predicting risk in hepatocellular carcinoma. Zhou D; Wang Y; Wei W; Zhou W; Gu J; Kong Y; Yang Q; Wu Y J Cancer Res Clin Oncol; 2023 Jul; 149(7):3661-3680. PubMed ID: 35972694 [TBL] [Abstract][Full Text] [Related]
6. Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer. Ji FH; Yang Z; Sun C; Lowe S; Qiu XG Clin Transl Oncol; 2023 Jan; 25(1):269-282. PubMed ID: 36163443 [TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment. Shi Y; Wang Y; Zhang W; Niu K; Mao X; Feng K; Zhang Y Front Endocrinol (Lausanne); 2023; 14():1153802. PubMed ID: 37469973 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
9. RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance. Zhao H; Zhou Q; Shi C; Shao Y; Ni J; Lou J; Wei S Med Sci Monit; 2021 Oct; 27():e930994. PubMed ID: 34690344 [TBL] [Abstract][Full Text] [Related]
10. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma. Meijing Z; Tianhang L; Biao Y Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200 [No Abstract] [Full Text] [Related]
11. m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma. Li J; Wang W; Zhou Y; Liu L; Zhang G; Guan K; Cui X; Liu X; Huang M; Cui G; Sun R Front Cell Dev Biol; 2021; 9():687756. PubMed ID: 34277630 [No Abstract] [Full Text] [Related]
12. N Li C; Zhu M; Gao C; Lu F; Chen H; Liu J; Zhong W Front Biosci (Landmark Ed); 2024 Jan; 29(1):33. PubMed ID: 38287827 [TBL] [Abstract][Full Text] [Related]
13. The m6A methylation landscape stratifies hepatocellular carcinoma into 3 subtypes with distinct metabolic characteristics. Shen X; Hu B; Xu J; Qin W; Fu Y; Wang S; Dong Q; Qin L Cancer Biol Med; 2020 Nov; 17(4):937-952. PubMed ID: 33299645 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of m6A regulators associated with immune infiltration in Hepatitis B virus-related hepatocellular carcinoma. Zhang Z; Gao W; Liu Z; Yu S; Jian H; Hou Z; Zeng P BMC Gastroenterol; 2023 Jul; 23(1):259. PubMed ID: 37507670 [TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma. Cai J; Zhou M; Xu J World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000 [TBL] [Abstract][Full Text] [Related]
16. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma. Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992 [TBL] [Abstract][Full Text] [Related]
17. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer. Liu X; Ma C; Liu H; Sun Z; Luo J J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer. Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X Front Immunol; 2022; 13():976107. PubMed ID: 36091006 [TBL] [Abstract][Full Text] [Related]
19. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment. Zhang W; Xiao P; Tang J; Wang R; Wang X; Wang F; Ruan J; Yu S; Tang J; Huang R; Zhao X Front Immunol; 2022; 13():888650. PubMed ID: 35572541 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma. Xiao Y; Li J; Wu J BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]